TransMedics Group Q2 2023 Earnings Report $67.05 -3.91 (-5.51%) As of 02:08 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Earnings HistoryForecast TransMedics Group EPS ResultsActual EPS-$0.03Consensus EPS -$0.15Beat/MissBeat by +$0.12One Year Ago EPS-$0.41TransMedics Group Revenue ResultsActual Revenue$42.46 millionExpected Revenue$42.42 millionBeat/MissBeat by +$40.00 thousandYoY Revenue Growth+136.90%TransMedics Group Announcement DetailsQuarterQ2 2023Date8/3/2023TimeAfter Market ClosesConference Call ResourcesConference CallConference Call TranscriptPress ReleaseTMDX Earnings HistoryConference Call AudioYour browser does not support the audio element. Listen Now.Powered by Remove Ads TransMedics Group Earnings HeadlinesScott+Scott Attorneys at Law LLP Reminds Investors of The Pending Class Action Against TransMedics Group, Inc. (TMDX)April 4 at 12:53 PM | markets.businessinsider.comTransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi ...April 4 at 6:12 AM | gurufocus.comEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and global powers like China, Russia, and even Europe rapidly moving away from the U.S. dollar, central banks and financial giants are frantically buying gold at historic rates. This massive shift threatens your retirement savings with inflation and market instability—potentially worse than 2008. But you can protect yourself today by leveraging a little-known IRS loophole that lets you diversify your IRA or 401(k) into gold—tax-free and penalty-free.April 4, 2025 | Colonial Metals (Ad)TransMedics Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 15, 2025 to Discuss Your Rights - TMDXApril 4 at 5:45 AM | prnewswire.comTMDX SECURITIES: BFA Law Reminds TransMedics Group Investors with Losses to Contact the Firm before the April 15 Class Action DeadlineApril 4 at 2:50 AM | markets.businessinsider.comTransMedics Group (TMDX) Financial Success Faces Legal Scrutiny Amid Allegations - Hagens BermanApril 4 at 2:50 AM | markets.businessinsider.comSee More TransMedics Group Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like TransMedics Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on TransMedics Group and other key companies, straight to your email. Email Address About TransMedics GroupTransMedics Group (NASDAQ:TMDX), a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.View TransMedics Group ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Lamb Weston Stock Rises, Earnings Provide Calm Amidst ChaosIntuitive Machines Gains After Earnings Beat, NASA Missions AheadCintas Delivers Earnings Beat, Signals More Growth AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go Higher Upcoming Earnings Bank of New York Mellon (4/11/2025)BlackRock (4/11/2025)JPMorgan Chase & Co. (4/11/2025)Progressive (4/11/2025)Wells Fargo & Company (4/11/2025)Interactive Brokers Group (4/15/2025)Bank of America (4/15/2025)Citigroup (4/15/2025)Johnson & Johnson (4/15/2025)Morgan Stanley (4/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
